Annals On Call Podcast podcast

SGLT2 vs GLP1 for Cardiovascular Prevention

0:00
23:05
Rewind 15 seconds
Fast Forward 15 seconds
Dr. Centor discusses the use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes with Dr. Elisabetta Patorno.

More episodes from "Annals On Call Podcast"